| pubmed-article:8790202 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8790202 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:8790202 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8790202 | lifeskim:mentions | umls-concept:C0067033 | lld:lifeskim |
| pubmed-article:8790202 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:8790202 | lifeskim:mentions | umls-concept:C0085101 | lld:lifeskim |
| pubmed-article:8790202 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:8790202 | pubmed:dateCreated | 1996-10-21 | lld:pubmed |
| pubmed-article:8790202 | pubmed:abstractText | The clinical feasibility of radioimmunotherapy (RIAIT) was assessed in patients with metastatic, carcinoembryonic antigen (CEA)-producing cancers who had minimal residual or small-volume disease (tumor lesions < or = 3 cm in diameter). | lld:pubmed |
| pubmed-article:8790202 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8790202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8790202 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8790202 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8790202 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8790202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8790202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8790202 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8790202 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:8790202 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:8790202 | pubmed:author | pubmed-author:SiegelJJ | lld:pubmed |
| pubmed-article:8790202 | pubmed:author | pubmed-author:GoldenbergD... | lld:pubmed |
| pubmed-article:8790202 | pubmed:author | pubmed-author:DunnRR | lld:pubmed |
| pubmed-article:8790202 | pubmed:author | pubmed-author:SharkeyR MRM | lld:pubmed |
| pubmed-article:8790202 | pubmed:author | pubmed-author:BehnPP | lld:pubmed |
| pubmed-article:8790202 | pubmed:author | pubmed-author:SwayneL CLC | lld:pubmed |
| pubmed-article:8790202 | pubmed:author | pubmed-author:JuweidM EME | lld:pubmed |
| pubmed-article:8790202 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8790202 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:8790202 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8790202 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8790202 | pubmed:pagination | 1504-10 | lld:pubmed |
| pubmed-article:8790202 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:meshHeading | pubmed-meshheading:8790202-... | lld:pubmed |
| pubmed-article:8790202 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8790202 | pubmed:articleTitle | Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. | lld:pubmed |
| pubmed-article:8790202 | pubmed:affiliation | Garden State Cancer Center, Center for Molecular Medicine and Immunology, Newark, New Jersey 07103, USA. | lld:pubmed |
| pubmed-article:8790202 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8790202 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
